Collage photo of Estela Rodriguez and Douglas Figg
Sep 29, 2024, 09:37
Estela Rodriguez: Douglas Figg on PKs- and finding the maximal effective dose in trials
Estela Rodriguez shared on X:
“Master talk by Doug Figg on PKs- and finding the maximal effective (not tolerated) dose in trials- navigating safety to innovation.”
Source: Estela Rodriguez/X
More posts featuring Estela Rodriguez on oncodaily.com
Estela (Estelamari) Rodriguez is Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and increasing access to clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 14:35
Dec 22, 2024, 14:32
Dec 22, 2024, 14:19
Dec 22, 2024, 13:56
Dec 22, 2024, 13:45